Christine Fiorentino, NP | |
1204 N Vercler Rd, Spokane Valley, WA 99216-1020 | |
(509) 228-1000 | |
(509) 252-9300 |
Full Name | Christine Fiorentino |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 11 Years |
Location | 1204 N Vercler Rd, Spokane Valley, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033531892 | NPI | - | NPPES |
2072541 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363L00000X | Nurse Practitioner | NP54103 (Idaho) | Secondary |
363L00000X | Nurse Practitioner | AP61090611 (Washington) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cancer Care Northwest Centers P S | 4688561939 | 41 |
News Archive
Rural residents who commonly seek treatment for advanced stages of colorectal cancer have been thought to lack access to cancer screening and adjuvant therapy. ... Several theories have been postulated to explain these findings, some of which include low socioeconomic status, lower educational attainment, lack of insurance coverage, underinsurance, and travel distance to health care facilities.
The Wall Street Journal on Wednesday examined how some hospitals have begun "taking steps to improve safety and reduce their own legal liability from mishaps" that occur during "thinly staffed" night and weekend shifts, when patients "suffer higher rates of death, complications and medical errors."
BioMarin Pharmaceutical Inc. announced today that Genzyme notified the company that, in rare circumstances, it has detected foreign particles in some products filled at the Allston Landing facility. To ensure that patients are not exposed to foreign particles during product administration, Genzyme has issued a "Dear Doctor" letter to all physicians treating patients with enzyme replacement products that it markets, including Aldurazyme.
Use of electronic health records by hospitals across the United States has had only a limited effect on improving the quality of medical care, according to a new RAND Corporation study.
MedGenesis Therapeutix Inc. ("MedGenesis"), a biopharmaceutical company developing and commercializing innovative treatments for patients with serious central nervous system (CNS) diseases, announced today that it has successfully entered into an agreement with Amgen Inc. ("Amgen"), granting MedGenesis an exclusive, worldwide license for glial cell line-derived neurotrophic factor (GDNF) protein in CNS and non-CNS indications, subject to the rights of a co-exclusive licensee for CNS indications in certain countries, as further described below.
› Verified 5 days ago
Entity Name | Cancer Care Northwest Centers P S |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922072081 PECOS PAC ID: 4688561939 Enrollment ID: O20040302000160 |
News Archive
Rural residents who commonly seek treatment for advanced stages of colorectal cancer have been thought to lack access to cancer screening and adjuvant therapy. ... Several theories have been postulated to explain these findings, some of which include low socioeconomic status, lower educational attainment, lack of insurance coverage, underinsurance, and travel distance to health care facilities.
The Wall Street Journal on Wednesday examined how some hospitals have begun "taking steps to improve safety and reduce their own legal liability from mishaps" that occur during "thinly staffed" night and weekend shifts, when patients "suffer higher rates of death, complications and medical errors."
BioMarin Pharmaceutical Inc. announced today that Genzyme notified the company that, in rare circumstances, it has detected foreign particles in some products filled at the Allston Landing facility. To ensure that patients are not exposed to foreign particles during product administration, Genzyme has issued a "Dear Doctor" letter to all physicians treating patients with enzyme replacement products that it markets, including Aldurazyme.
Use of electronic health records by hospitals across the United States has had only a limited effect on improving the quality of medical care, according to a new RAND Corporation study.
MedGenesis Therapeutix Inc. ("MedGenesis"), a biopharmaceutical company developing and commercializing innovative treatments for patients with serious central nervous system (CNS) diseases, announced today that it has successfully entered into an agreement with Amgen Inc. ("Amgen"), granting MedGenesis an exclusive, worldwide license for glial cell line-derived neurotrophic factor (GDNF) protein in CNS and non-CNS indications, subject to the rights of a co-exclusive licensee for CNS indications in certain countries, as further described below.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Christine Fiorentino, NP 1204 N Vercler Rd, Spokane Valley, WA 99216-1020 Ph: (509) 228-1000 | Christine Fiorentino, NP 1204 N Vercler Rd, Spokane Valley, WA 99216-1020 Ph: (509) 228-1000 |
News Archive
Rural residents who commonly seek treatment for advanced stages of colorectal cancer have been thought to lack access to cancer screening and adjuvant therapy. ... Several theories have been postulated to explain these findings, some of which include low socioeconomic status, lower educational attainment, lack of insurance coverage, underinsurance, and travel distance to health care facilities.
The Wall Street Journal on Wednesday examined how some hospitals have begun "taking steps to improve safety and reduce their own legal liability from mishaps" that occur during "thinly staffed" night and weekend shifts, when patients "suffer higher rates of death, complications and medical errors."
BioMarin Pharmaceutical Inc. announced today that Genzyme notified the company that, in rare circumstances, it has detected foreign particles in some products filled at the Allston Landing facility. To ensure that patients are not exposed to foreign particles during product administration, Genzyme has issued a "Dear Doctor" letter to all physicians treating patients with enzyme replacement products that it markets, including Aldurazyme.
Use of electronic health records by hospitals across the United States has had only a limited effect on improving the quality of medical care, according to a new RAND Corporation study.
MedGenesis Therapeutix Inc. ("MedGenesis"), a biopharmaceutical company developing and commercializing innovative treatments for patients with serious central nervous system (CNS) diseases, announced today that it has successfully entered into an agreement with Amgen Inc. ("Amgen"), granting MedGenesis an exclusive, worldwide license for glial cell line-derived neurotrophic factor (GDNF) protein in CNS and non-CNS indications, subject to the rights of a co-exclusive licensee for CNS indications in certain countries, as further described below.
› Verified 5 days ago
Kathrine Omalley, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1415 N Houk Rd Ste A, Spokane Valley, WA 99216 Phone: 509-924-1990 Fax: 509-232-3059 | |
Julia Anne Platt, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 15812 E Indiana Ave, Spokane Valley, WA 99216 Phone: 509-444-8200 | |
Clara Simpson, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1215 N Mcdonald Rd Ste 101, Spokane Valley, WA 99216 Phone: 509-598-7750 | |
Samantha K Knapp, DNP, ARNP, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 15812 E Indiana Ave, Spokane Valley, WA 99216 Phone: 509-444-8200 | |
Julie K Tveit, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1414 N Vercler Rd, Building 1, Spokane Valley, WA 99216 Phone: 509-928-6383 Fax: 509-926-9420 | |
Tiffany A Long, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1123 N Evergreen Rd, Spokane Valley, WA 99216 Phone: 509-363-3100 Fax: 509-363-0300 |